Force Degradation Study of Tenofovir Disoproxil Fumarate by UV-Spectrophotometric Method

Authors

  • Debaje Priyanka D Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik
  • Chavan Harishchandra H Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik

DOI:

https://doi.org/10.22270/ajprd.v8i2.679

Keywords:

Tenofovir disoproxil Fumarate, UV Spectroscopy, Forced Degradation study

Abstract

Tenofovir disoproxil Fumarate (TDF), acyclic phosphonate nucleotide analogue, used as antiretroviral agents in the treatment of HIV-1 infection.  A stability indicating UV -spectrophotometric method is simple, an accurate and economic, precise and reproducible method has been used for the estimation of Tenofovir disoproxil Fumarate in bulk and tablets dosage form in present work. The wavelength selected for the absorption correction method was 260 nm. The linearity range of 2-10μg/ml proved that it obeyed Beer’s Law and the correlation coefficient (r2) was found to be 0.999 at 260 nm. The drug was subjected to acid, alkali, peroxide, UV and Heat degradation. The force degradation studies of Tenofovir disoproxil Fumarate was done on Stress degradation by hydrolysis under alkaline condition by using 0.1N NAOH was found to be 10.6%. Stress degradation by hydrolysis under acidic condition by using 0.1N HCl and product degradation was found to be 10.95%. Oxidative degradation was done by using hydrogen peroxide and product degradation was found to be 12.22%. Neutral hydrolytic degradation was found to be 12.26%. Forced degradation studies of drug reveal good stability under the chosen experimental conditions.

 

Downloads

Download data is not yet available.

Author Biographies

Debaje Priyanka D, Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik

Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik

Chavan Harishchandra H, Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik

Department of Pharmaceutics, Sandip Institute of Pharmaceutical Sciences, Nashik

References

1. ICH, Stability Testing of New Drug Substances and Products. International Conference on Harmonization, IFPMA, Geneva, 1993.
2. ICH, Impurities in New Drug Products. International Conference on Harmonization, IFPMA, Geneva, 1996.
3. Budavari S, editor. The Merck Index. 13th ed. White House Station, NJ: Merck and Co. Inc; 200; 1628.
4. ICH, Q2A, Text on Validation of Analylical procedures, International Conference on Harmonization, Geneva,octomber 1994:1-5.
5. Christen, G.D.Analytical Chemistry 6th edition, John Wiley and Sons. 2003; 6:13l-l32
6. Kasture, A.V.; Mahadik, K.R.; Wadodkar, S.G. pharmaceutical Analysis Nirali Prakashan 1:5-7, 28-30.
7. Sharma B. Instrumental Method of analysis. 21st edition, Goel Publishing House. 2006: 6
8. Havele S., Dhaneshwar S. Stress Studies of Tenofovir Disoproxil Fumarate by HPTLC in Bulk Drug and Pharmaceutical Formulation. 2011: 6
9. Bhattacharyya S., Choudhury P. etb al. Estimation and Validation of Stability Indicating UV Spectrophotometric Method For The Determination Of Guaifenesin In Presence Of Its Degradant Products. 2013; 5:262-268.
10. Bojjagani R. Madasu S. Method Development and Validation of Forced Degradation Studies of Pioglitazone Hydrochloride by Using UV Spectroscopy.2012; 4:1750-1757.
11. Hossain F., Bhadra S. et al. The ICH guidance in practice: Stress degradation studies on aceclofenac and development of a validated stability-indicating reversed-phase HPLC assay in tablet dosage form.2013; 5:131-146.
12. Blessy M., PatelR.et al. Development of forced degradation and stability indicating studies of drugs. A review.2013; 5: 159–165.
13. Khagga B., Balaram V. et al. Development and Validation of Forced Degradation Studies of Atazanavir Using RP-HPLC and Characterization of Degradants by LC-MS/MS. 2015; 33(03):11-15.
14. S. Singh and M. Bakshi, “Guidance on conduct of stress tests to determine inherent stability of drugs,” Pharmaceutical Technology Online 2000; 24:1–143
15. S. Singh and M. Bakshi, “Development of validated stability indicating assay methods critical review,” Journal of Pharmaceutical and Biomedical Analysis, 2002; 28(6):1011–1040
16. Reynolds D., Facchine K. et al. Available guidance and best practices for conducting forced degradation studies, Pharm. Technol. 2002;26(3):48–56.
17. El-Saharty Y., Refaat M., et al. Stability- Indicating spectrophotometric and densitometric methods for determination of aceclofenac. Drug Dev. Ind. Pharm. vol. 28 No. 5, 2000; 28(5):571–582.
18. Grosa G, Grooso ED, Russo R, Allergrone G. Simultaneous, stability-indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup .J Pharm Biomed Anal.2006; 41:298-803.

Published

2020-04-15

How to Cite

D, D. P., & H, C. H. (2020). Force Degradation Study of Tenofovir Disoproxil Fumarate by UV-Spectrophotometric Method. Asian Journal of Pharmaceutical Research and Development, 8(2), 21–25. https://doi.org/10.22270/ajprd.v8i2.679

Issue

Vol. 8 No. 2 (2020): Vol 8 No 2 (2020): Volume 8 Issue 2 March - April. 2020

Section

Research Articles

AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).